Research field：
His research focuses on neurodevelopmental disorders: autism spectrum disorder, attention deficit hyperactivity disorder, developmental delay, speech and language disorder, and prevention and treatment technology of rare neuromuscular diseases.
Medical expertise：
Specializes in neurodevelopmental disorders: autism spectrum disorder, attention deficit hyperactivity disorder, developmental delay, speech and language disorder and rare neuromuscular diseases diagnosis, assessment of the development of rehabilitation programs.
Introduction：
Zhou Hao, MD, postdoctoral, chief physician, doctoral supervisor, selected as the provincial "Thousand level" talents, director of the rehabilitation department of Children's Hospital of Fudan University, member of the provincial autism diagnosis and treatment expert group, as the main participant in the introduction of the latest international autism early intervention technology (ESDM early Denver intervention model) to China. He has hosted and participated in 15 National Natural Science Foundation of China and provincial and ministerial projects, and has published more than 100 papers, including more than 40 SCI papers. His landmark research achievement, the multi-center epidemiological study of autism in children in China, was awarded the Grand Prize of excellent paper by the domestic outstanding journal Neuroscience Bulletin. He has edited and translated 4 monographs. He has been a review expert of the National Natural Science Foundation of China and a reviewer of internationally renowned journals such as Autism research, Frontiers in pediatrics, and Frontiers in psychiatry.
